Christoph Lengauer

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christoph Lengauer:

Company Role Class Num Shares Value Price $ Report Date Ownership
HOOKIPA Pharma Inc. Director Stock Option (Right to Buy) 9,600 $28,800 $3.00 01 Jun 2021 Direct

Insider Reports Filed by Christoph Lengauer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HOOK HOOKIPA Pharma Inc. 01 Jun 2021 1 $0 4 Director 04 Jun 2021, 20:35